[Epoch Times] The proposal to implement a pharmaceutical drug import plan by the Trump administration is being met with opposition by drug makers and researchers who call the plan a dangerous scheme.
But Marc-André Gagnon, a pharmaceutical policy researcher at Carleton University in Ontario, Canada, and Master of Advanced Studies in Economics, said he doesn’t buy into all the negativity.
"There’s a bit of a fear-mongering campaign in Canada that this type of proposal will be a catastrophe, people will die, the pharmacy shelves will be empty," said Gagnon. "So it’s all about drug shortages in Canada."
OR it's a move that will more evenly spread the costs past the American consumers. Why should foreigners receive discounts while the citizens of the country that created the drugs pay more? "Because they can"
The proposed program would allow states, pharmacies, and drug distributors to develop pilot programs to import drugs from other countries, primarily Canada. |